Biologically Active Small Molecules

A broad-spectrum antibiotic with a prolonged serum elimination half-life in animals.

A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 &microg/ml inhibits 90% of S. aureus growth).

A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 &microg/ml inhibits 90% of S. aureus growth).

A cephalosporin antibiotic that is active in vitro against most Gram-positive and Gram-negative bacteria, including &beta-lactamase strains (3-4 &microg/ml inhibits 90% of S. aureus growth).

A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC₅₀ = 2 &microg/ml) and penicillin-resistant S.

A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC₅₀ = 2 &microg/ml) and penicillin-resistant S.

A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC₅₀ = 2 &microg/ml) and penicillin-resistant S.

A cephalosporin antibiotic with potent in vitro activity against streptococcal species, including S. aureus (IC₅₀ = 2 &microg/ml) and penicillin-resistant S.

A second generation cephalosporin antibiotic that has been used to treat a wide range of gram-negative and gram-positive bacteria including anaerobes.

A second generation cephalosporin antibiotic that has been used to treat a wide range of gram-negative and gram-positive bacteria including anaerobes.

A second generation cephalosporin antibiotic that has been used to treat a wide range of gram-negative and gram-positive bacteria including anaerobes.

A metabolite of cefpodoxime proxetil, the oral third generation cephalosporin antibiotic that demonstrates potent activity against most Gram-positive and Gram-negative bacteria (MIC90 ranges from 0.015-8 &microg/ml).